| |
|
|
|
Nymox Pharm Corp  
|
|
3.71 0.25 (0.07%) |
06-02 16:00 |
|
Open: |
3.42 |
Pre close: |
3.46 |
Target:
|
4.38 
|
|
High: |
3.75 |
Low: |
3.42 |
Resistance:
|
3.75
4.38
|
|
Volume: |
270,563 |
Market Cap: |
266M |
Support:
|
3.14
2.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.48
|
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
3.28 |
Signal(12,26,9): |
0.20 |
|
MA(100): |
2.83 |
Stochastic Oscillator |
%K(14,3):
|
94.68 |
|
MA(250): |
2.25 |
%D(3): |
91.23 |
|
Average Volume(K) |
3-Month: |
12906
|
52-Week |
High:
|
4.09 |
|
10-Days: |
16026 |
Low: |
1.32 |
|
RSI |
RSI(14):
|
74.59 |
Change(%): |
137.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.191 |
Return on Equity (ttm) |
-223.9 |
Shares Out. (M) |
71.72 |
|
EPS Est. Current Year |
-0.200 |
Return on Assets (ttm) |
-107.5 |
Shares Float (M) |
38.53 |
|
EPS Est. Next Year |
-0.570 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.94 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-83.3 |
% Held by Institutions |
2.55 |
|
Forward EPS |
-0.180 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
3270 |
|
Book Value (p.s.) |
0.020 |
EBITDA (p.s.) |
-0.178 |
P/E |
-19.42 |
|
Sales Per Share |
0.001 |
Qtrly Earnings Growth |
0.00 |
P/BV |
185.50 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.01 |
P/S |
2923.97 |
|
Operating Margin |
-14331.87 |
Levered Free Cash Flow
(M) |
-3.04 |
P/CF |
-33.22 |
|
|
|
|
|
|
